HCW Biologics (HCWB) Short-term Investments (2021 - 2023)

HCW Biologics (HCWB) has 3 years of Short-term Investments data on file, last reported at $10.0 million in Q2 2023.

• Quarterly Short-term Investments fell 41.39% year-over-year to $10.0 million in Q2 2023, while the trailing twelve-month figure through Jun 2023 was $10.0 million (down 41.39% YoY) and the FY2022 annual result came in at $9.7 million, down 61.03% from the prior year.
• Short-term Investments improved to $10.0 million in Q2 2023, from $9.8 million in the prior quarter.
• In the past five years, Short-term Investments ranged from a high of $25.0 million in Q3 2021 to a low of $9.7 million in Q4 2022.
• A 3-year average of $16.2 million and a median of $17.0 million in 2022 frame the typical range for Short-term Investments.
• Annual changes were most pronounced in 2022 — Short-term Investments tumbled 61.03% — and 2023, when it sank 41.39%.
• Tracing HCWB's Short-term Investments over 3 years: stood at $25.0 million in 2021, then plunged by 61.03% to $9.7 million in 2022, then increased by 2.3% to $10.0 million in 2023.
• The last three Short-term Investments figures came in at $10.0 million (Q2 2023), $9.8 million (Q1 2023), and $9.7 million (Q4 2022), per Business Quant data.